nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Ezetimibe—atherosclerosis	0.0437	0.211	CbGbCtD
Brinzolamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0437	0.211	CbGbCtD
Brinzolamide—CYP3A4—Simvastatin—atherosclerosis	0.0406	0.196	CbGbCtD
Brinzolamide—CYP3A4—Pravastatin—atherosclerosis	0.0398	0.192	CbGbCtD
Brinzolamide—CYP3A4—Lovastatin—atherosclerosis	0.0398	0.192	CbGbCtD
Brinzolamide—Infestation—Ezetimibe—atherosclerosis	0.00292	0.00441	CcSEcCtD
Brinzolamide—Erectile dysfunction—Simvastatin—atherosclerosis	0.00288	0.00435	CcSEcCtD
Brinzolamide—Arrhythmia—Rosuvastatin—atherosclerosis	0.00282	0.00426	CcSEcCtD
Brinzolamide—Angina pectoris—Niacin—atherosclerosis	0.00279	0.00422	CcSEcCtD
Brinzolamide—Sinusitis—Lovastatin—atherosclerosis	0.00279	0.00422	CcSEcCtD
Brinzolamide—Depression—Simvastatin—atherosclerosis	0.00278	0.0042	CcSEcCtD
Brinzolamide—Mental disorder—Rosuvastatin—atherosclerosis	0.00276	0.00417	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00276	0.00417	CcSEcCtD
Brinzolamide—Bronchitis—Niacin—atherosclerosis	0.00276	0.00417	CcSEcCtD
Brinzolamide—Angina pectoris—Pravastatin—atherosclerosis	0.00275	0.00416	CcSEcCtD
Brinzolamide—Sinusitis—Ezetimibe—atherosclerosis	0.00274	0.00414	CcSEcCtD
Brinzolamide—Flatulence—Rosuvastatin—atherosclerosis	0.00271	0.00409	CcSEcCtD
Brinzolamide—Erectile dysfunction—Niacin—atherosclerosis	0.00264	0.00399	CcSEcCtD
Brinzolamide—Sinusitis—Simvastatin—atherosclerosis	0.00261	0.00395	CcSEcCtD
Brinzolamide—Pharyngitis—Ezetimibe—atherosclerosis	0.0026	0.00393	CcSEcCtD
Brinzolamide—Erectile dysfunction—Pravastatin—atherosclerosis	0.0026	0.00393	CcSEcCtD
Brinzolamide—Oedema peripheral—Ezetimibe—atherosclerosis	0.00258	0.0039	CcSEcCtD
Brinzolamide—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00258	0.00389	CcSEcCtD
Brinzolamide—Depression—Pravastatin—atherosclerosis	0.00251	0.00379	CcSEcCtD
Brinzolamide—Cough—Rosuvastatin—atherosclerosis	0.0024	0.00362	CcSEcCtD
Brinzolamide—Angiopathy—Ezetimibe—atherosclerosis	0.00238	0.00359	CcSEcCtD
Brinzolamide—Immune system disorder—Ezetimibe—atherosclerosis	0.00237	0.00358	CcSEcCtD
Brinzolamide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00236	0.00357	CcSEcCtD
Brinzolamide—Sinusitis—Pravastatin—atherosclerosis	0.00236	0.00357	CcSEcCtD
Brinzolamide—Alopecia—Lovastatin—atherosclerosis	0.00236	0.00357	CcSEcCtD
Brinzolamide—Myalgia—Rosuvastatin—atherosclerosis	0.00234	0.00353	CcSEcCtD
Brinzolamide—Arthralgia—Rosuvastatin—atherosclerosis	0.00234	0.00353	CcSEcCtD
Brinzolamide—Alopecia—Ezetimibe—atherosclerosis	0.00232	0.0035	CcSEcCtD
Brinzolamide—Rhinitis—Niacin—atherosclerosis	0.0023	0.00348	CcSEcCtD
Brinzolamide—Mental disorder—Ezetimibe—atherosclerosis	0.0023	0.00347	CcSEcCtD
Brinzolamide—Flatulence—Lovastatin—atherosclerosis	0.00229	0.00346	CcSEcCtD
Brinzolamide—Hypoaesthesia—Niacin—atherosclerosis	0.00228	0.00345	CcSEcCtD
Brinzolamide—Malnutrition—Ezetimibe—atherosclerosis	0.00228	0.00345	CcSEcCtD
Brinzolamide—Erythema—Ezetimibe—atherosclerosis	0.00228	0.00345	CcSEcCtD
Brinzolamide—Dysgeusia—Lovastatin—atherosclerosis	0.00228	0.00344	CcSEcCtD
Brinzolamide—Rhinitis—Pravastatin—atherosclerosis	0.00227	0.00342	CcSEcCtD
Brinzolamide—Oedema peripheral—Niacin—atherosclerosis	0.00226	0.00342	CcSEcCtD
Brinzolamide—Back pain—Lovastatin—atherosclerosis	0.00225	0.0034	CcSEcCtD
Brinzolamide—Hypoaesthesia—Pravastatin—atherosclerosis	0.00225	0.0034	CcSEcCtD
Brinzolamide—Flatulence—Ezetimibe—atherosclerosis	0.00225	0.0034	CcSEcCtD
Brinzolamide—Pharyngitis—Pravastatin—atherosclerosis	0.00224	0.00339	CcSEcCtD
Brinzolamide—Muscle spasms—Lovastatin—atherosclerosis	0.00224	0.00338	CcSEcCtD
Brinzolamide—Infection—Rosuvastatin—atherosclerosis	0.00223	0.00336	CcSEcCtD
Brinzolamide—Visual impairment—Niacin—atherosclerosis	0.00221	0.00334	CcSEcCtD
Brinzolamide—Alopecia—Simvastatin—atherosclerosis	0.00221	0.00334	CcSEcCtD
Brinzolamide—Back pain—Ezetimibe—atherosclerosis	0.00221	0.00334	CcSEcCtD
Brinzolamide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.0022	0.00332	CcSEcCtD
Brinzolamide—Muscle spasms—Ezetimibe—atherosclerosis	0.00219	0.00332	CcSEcCtD
Brinzolamide—Vision blurred—Lovastatin—atherosclerosis	0.00219	0.00331	CcSEcCtD
Brinzolamide—Mental disorder—Simvastatin—atherosclerosis	0.00219	0.00331	CcSEcCtD
Brinzolamide—Tremor—Lovastatin—atherosclerosis	0.00218	0.00329	CcSEcCtD
Brinzolamide—Visual impairment—Pravastatin—atherosclerosis	0.00218	0.00329	CcSEcCtD
Brinzolamide—Erythema—Simvastatin—atherosclerosis	0.00218	0.00329	CcSEcCtD
Brinzolamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.00216	0.00326	CcSEcCtD
Brinzolamide—Eye disorder—Niacin—atherosclerosis	0.00215	0.00324	CcSEcCtD
Brinzolamide—Flatulence—Simvastatin—atherosclerosis	0.00214	0.00324	CcSEcCtD
Brinzolamide—Tinnitus—Niacin—atherosclerosis	0.00214	0.00323	CcSEcCtD
Brinzolamide—Dysgeusia—Simvastatin—atherosclerosis	0.00213	0.00322	CcSEcCtD
Brinzolamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00212	0.0032	CcSEcCtD
Brinzolamide—Tinnitus—Pravastatin—atherosclerosis	0.00211	0.00318	CcSEcCtD
Brinzolamide—Malaise—Lovastatin—atherosclerosis	0.0021	0.00317	CcSEcCtD
Brinzolamide—Cardiac disorder—Pravastatin—atherosclerosis	0.0021	0.00317	CcSEcCtD
Brinzolamide—Muscle spasms—Simvastatin—atherosclerosis	0.00209	0.00316	CcSEcCtD
Brinzolamide—Vertigo—Lovastatin—atherosclerosis	0.00209	0.00316	CcSEcCtD
Brinzolamide—Angiopathy—Niacin—atherosclerosis	0.00208	0.00315	CcSEcCtD
Brinzolamide—Malaise—Ezetimibe—atherosclerosis	0.00206	0.00311	CcSEcCtD
Brinzolamide—Vision blurred—Simvastatin—atherosclerosis	0.00205	0.0031	CcSEcCtD
Brinzolamide—Arrhythmia—Niacin—atherosclerosis	0.00205	0.0031	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00204	0.00308	CcSEcCtD
Brinzolamide—Tremor—Simvastatin—atherosclerosis	0.00204	0.00308	CcSEcCtD
Brinzolamide—Alopecia—Niacin—atherosclerosis	0.00203	0.00306	CcSEcCtD
Brinzolamide—Insomnia—Rosuvastatin—atherosclerosis	0.00203	0.00306	CcSEcCtD
Brinzolamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.00202	0.00305	CcSEcCtD
Brinzolamide—Arrhythmia—Pravastatin—atherosclerosis	0.00202	0.00305	CcSEcCtD
Brinzolamide—Palpitations—Ezetimibe—atherosclerosis	0.00202	0.00305	CcSEcCtD
Brinzolamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00201	0.00304	CcSEcCtD
Brinzolamide—Erythema—Niacin—atherosclerosis	0.002	0.00302	CcSEcCtD
Brinzolamide—Malnutrition—Niacin—atherosclerosis	0.002	0.00302	CcSEcCtD
Brinzolamide—Alopecia—Pravastatin—atherosclerosis	0.002	0.00302	CcSEcCtD
Brinzolamide—Cough—Ezetimibe—atherosclerosis	0.00199	0.00301	CcSEcCtD
Brinzolamide—Arthralgia—Lovastatin—atherosclerosis	0.00198	0.00299	CcSEcCtD
Brinzolamide—Chest pain—Lovastatin—atherosclerosis	0.00198	0.00299	CcSEcCtD
Brinzolamide—Myalgia—Lovastatin—atherosclerosis	0.00198	0.00299	CcSEcCtD
Brinzolamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.00197	0.00298	CcSEcCtD
Brinzolamide—Hypertension—Ezetimibe—atherosclerosis	0.00197	0.00298	CcSEcCtD
Brinzolamide—Flatulence—Niacin—atherosclerosis	0.00197	0.00298	CcSEcCtD
Brinzolamide—Malaise—Simvastatin—atherosclerosis	0.00196	0.00297	CcSEcCtD
Brinzolamide—Tension—Niacin—atherosclerosis	0.00196	0.00296	CcSEcCtD
Brinzolamide—Discomfort—Lovastatin—atherosclerosis	0.00196	0.00296	CcSEcCtD
Brinzolamide—Vertigo—Simvastatin—atherosclerosis	0.00196	0.00295	CcSEcCtD
Brinzolamide—Arthralgia—Ezetimibe—atherosclerosis	0.00194	0.00294	CcSEcCtD
Brinzolamide—Myalgia—Ezetimibe—atherosclerosis	0.00194	0.00294	CcSEcCtD
Brinzolamide—Chest pain—Ezetimibe—atherosclerosis	0.00194	0.00294	CcSEcCtD
Brinzolamide—Nervousness—Niacin—atherosclerosis	0.00194	0.00293	CcSEcCtD
Brinzolamide—Flatulence—Pravastatin—atherosclerosis	0.00194	0.00293	CcSEcCtD
Brinzolamide—Dry mouth—Lovastatin—atherosclerosis	0.00194	0.00293	CcSEcCtD
Brinzolamide—Tension—Pravastatin—atherosclerosis	0.00193	0.00292	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00193	0.00292	CcSEcCtD
Brinzolamide—Dysgeusia—Pravastatin—atherosclerosis	0.00193	0.00291	CcSEcCtD
Brinzolamide—Muscle spasms—Niacin—atherosclerosis	0.00192	0.0029	CcSEcCtD
Brinzolamide—Discomfort—Ezetimibe—atherosclerosis	0.00192	0.0029	CcSEcCtD
Brinzolamide—Pain—Rosuvastatin—atherosclerosis	0.00192	0.0029	CcSEcCtD
Brinzolamide—Nervousness—Pravastatin—atherosclerosis	0.00191	0.00289	CcSEcCtD
Brinzolamide—Dry mouth—Ezetimibe—atherosclerosis	0.0019	0.00287	CcSEcCtD
Brinzolamide—Muscle spasms—Pravastatin—atherosclerosis	0.00189	0.00286	CcSEcCtD
Brinzolamide—Infection—Lovastatin—atherosclerosis	0.00189	0.00285	CcSEcCtD
Brinzolamide—Vision blurred—Niacin—atherosclerosis	0.00188	0.00285	CcSEcCtD
Brinzolamide—Vision blurred—Pravastatin—atherosclerosis	0.00185	0.0028	CcSEcCtD
Brinzolamide—Chest pain—Simvastatin—atherosclerosis	0.00185	0.0028	CcSEcCtD
Brinzolamide—Myalgia—Simvastatin—atherosclerosis	0.00185	0.0028	CcSEcCtD
Brinzolamide—Arthralgia—Simvastatin—atherosclerosis	0.00185	0.0028	CcSEcCtD
Brinzolamide—Infection—Ezetimibe—atherosclerosis	0.00185	0.0028	CcSEcCtD
Brinzolamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00185	0.00279	CcSEcCtD
Brinzolamide—Tremor—Pravastatin—atherosclerosis	0.00184	0.00279	CcSEcCtD
Brinzolamide—Discomfort—Simvastatin—atherosclerosis	0.00183	0.00277	CcSEcCtD
Brinzolamide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00183	0.00276	CcSEcCtD
Brinzolamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.00183	0.00276	CcSEcCtD
Brinzolamide—Skin disorder—Ezetimibe—atherosclerosis	0.00181	0.00273	CcSEcCtD
Brinzolamide—Vertigo—Niacin—atherosclerosis	0.0018	0.00271	CcSEcCtD
Brinzolamide—Urticaria—Rosuvastatin—atherosclerosis	0.00178	0.00269	CcSEcCtD
Brinzolamide—Malaise—Pravastatin—atherosclerosis	0.00177	0.00268	CcSEcCtD
Brinzolamide—Vertigo—Pravastatin—atherosclerosis	0.00177	0.00267	CcSEcCtD
Brinzolamide—Palpitations—Niacin—atherosclerosis	0.00177	0.00267	CcSEcCtD
Brinzolamide—Infection—Simvastatin—atherosclerosis	0.00176	0.00267	CcSEcCtD
Brinzolamide—Cough—Niacin—atherosclerosis	0.00174	0.00263	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00173	0.00261	CcSEcCtD
Brinzolamide—Insomnia—Lovastatin—atherosclerosis	0.00172	0.00259	CcSEcCtD
Brinzolamide—Cough—Pravastatin—atherosclerosis	0.00172	0.00259	CcSEcCtD
Brinzolamide—Paraesthesia—Lovastatin—atherosclerosis	0.00171	0.00258	CcSEcCtD
Brinzolamide—Myalgia—Niacin—atherosclerosis	0.0017	0.00257	CcSEcCtD
Brinzolamide—Arthralgia—Niacin—atherosclerosis	0.0017	0.00257	CcSEcCtD
Brinzolamide—Hypertension—Pravastatin—atherosclerosis	0.0017	0.00257	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0017	0.00256	CcSEcCtD
Brinzolamide—Dyspnoea—Lovastatin—atherosclerosis	0.00169	0.00256	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00169	0.00255	CcSEcCtD
Brinzolamide—Insomnia—Ezetimibe—atherosclerosis	0.00168	0.00255	CcSEcCtD
Brinzolamide—Arthralgia—Pravastatin—atherosclerosis	0.00168	0.00253	CcSEcCtD
Brinzolamide—Chest pain—Pravastatin—atherosclerosis	0.00168	0.00253	CcSEcCtD
Brinzolamide—Myalgia—Pravastatin—atherosclerosis	0.00168	0.00253	CcSEcCtD
Brinzolamide—Paraesthesia—Ezetimibe—atherosclerosis	0.00167	0.00253	CcSEcCtD
Brinzolamide—Dyspepsia—Lovastatin—atherosclerosis	0.00167	0.00253	CcSEcCtD
Brinzolamide—Dry mouth—Niacin—atherosclerosis	0.00166	0.00251	CcSEcCtD
Brinzolamide—Dyspnoea—Ezetimibe—atherosclerosis	0.00166	0.00251	CcSEcCtD
Brinzolamide—Discomfort—Pravastatin—atherosclerosis	0.00166	0.0025	CcSEcCtD
Brinzolamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00165	0.00249	CcSEcCtD
Brinzolamide—Decreased appetite—Lovastatin—atherosclerosis	0.00165	0.00249	CcSEcCtD
Brinzolamide—Dyspepsia—Ezetimibe—atherosclerosis	0.00164	0.00248	CcSEcCtD
Brinzolamide—Fatigue—Lovastatin—atherosclerosis	0.00164	0.00247	CcSEcCtD
Brinzolamide—Pain—Lovastatin—atherosclerosis	0.00162	0.00245	CcSEcCtD
Brinzolamide—Decreased appetite—Ezetimibe—atherosclerosis	0.00162	0.00245	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00162	0.00244	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00161	0.00243	CcSEcCtD
Brinzolamide—Asthenia—Rosuvastatin—atherosclerosis	0.00161	0.00243	CcSEcCtD
Brinzolamide—Insomnia—Simvastatin—atherosclerosis	0.00161	0.00243	CcSEcCtD
Brinzolamide—Fatigue—Ezetimibe—atherosclerosis	0.00161	0.00243	CcSEcCtD
Brinzolamide—Infection—Pravastatin—atherosclerosis	0.0016	0.00241	CcSEcCtD
Brinzolamide—Paraesthesia—Simvastatin—atherosclerosis	0.0016	0.00241	CcSEcCtD
Brinzolamide—Pain—Ezetimibe—atherosclerosis	0.00159	0.00241	CcSEcCtD
Brinzolamide—Tachycardia—Niacin—atherosclerosis	0.00159	0.0024	CcSEcCtD
Brinzolamide—Pruritus—Rosuvastatin—atherosclerosis	0.00159	0.0024	CcSEcCtD
Brinzolamide—Skin disorder—Niacin—atherosclerosis	0.00158	0.00239	CcSEcCtD
Brinzolamide—Dyspnoea—Simvastatin—atherosclerosis	0.00158	0.00239	CcSEcCtD
Brinzolamide—Feeling abnormal—Lovastatin—atherosclerosis	0.00157	0.00236	CcSEcCtD
Brinzolamide—Dyspepsia—Simvastatin—atherosclerosis	0.00156	0.00236	CcSEcCtD
Brinzolamide—Decreased appetite—Simvastatin—atherosclerosis	0.00154	0.00233	CcSEcCtD
Brinzolamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00154	0.00232	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00153	0.00232	CcSEcCtD
Brinzolamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00153	0.00232	CcSEcCtD
Brinzolamide—Fatigue—Simvastatin—atherosclerosis	0.00153	0.00231	CcSEcCtD
Brinzolamide—Hypotension—Niacin—atherosclerosis	0.00152	0.0023	CcSEcCtD
Brinzolamide—Pain—Simvastatin—atherosclerosis	0.00152	0.00229	CcSEcCtD
Brinzolamide—Urticaria—Lovastatin—atherosclerosis	0.00151	0.00228	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00149	0.00225	CcSEcCtD
Brinzolamide—Dizziness—Rosuvastatin—atherosclerosis	0.00148	0.00224	CcSEcCtD
Brinzolamide—Urticaria—Ezetimibe—atherosclerosis	0.00148	0.00224	CcSEcCtD
Brinzolamide—Insomnia—Niacin—atherosclerosis	0.00148	0.00223	CcSEcCtD
Brinzolamide—Paraesthesia—Niacin—atherosclerosis	0.00146	0.00221	CcSEcCtD
Brinzolamide—Feeling abnormal—Simvastatin—atherosclerosis	0.00146	0.00221	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00146	0.00221	CcSEcCtD
Brinzolamide—Dyspnoea—Niacin—atherosclerosis	0.00145	0.0022	CcSEcCtD
Brinzolamide—Insomnia—Pravastatin—atherosclerosis	0.00145	0.00219	CcSEcCtD
Brinzolamide—Somnolence—Niacin—atherosclerosis	0.00145	0.00219	CcSEcCtD
Brinzolamide—Paraesthesia—Pravastatin—atherosclerosis	0.00144	0.00218	CcSEcCtD
Brinzolamide—Dyspepsia—Niacin—atherosclerosis	0.00144	0.00217	CcSEcCtD
Brinzolamide—Dyspnoea—Pravastatin—atherosclerosis	0.00143	0.00216	CcSEcCtD
Brinzolamide—Decreased appetite—Niacin—atherosclerosis	0.00142	0.00214	CcSEcCtD
Brinzolamide—Dyspepsia—Pravastatin—atherosclerosis	0.00141	0.00214	CcSEcCtD
Brinzolamide—Rash—Rosuvastatin—atherosclerosis	0.00141	0.00213	CcSEcCtD
Brinzolamide—Dermatitis—Rosuvastatin—atherosclerosis	0.00141	0.00213	CcSEcCtD
Brinzolamide—Urticaria—Simvastatin—atherosclerosis	0.00141	0.00213	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.00141	0.00213	CcSEcCtD
Brinzolamide—Headache—Rosuvastatin—atherosclerosis	0.0014	0.00212	CcSEcCtD
Brinzolamide—Hypersensitivity—Lovastatin—atherosclerosis	0.0014	0.00211	CcSEcCtD
Brinzolamide—Decreased appetite—Pravastatin—atherosclerosis	0.0014	0.00211	CcSEcCtD
Brinzolamide—Pain—Niacin—atherosclerosis	0.00139	0.00211	CcSEcCtD
Brinzolamide—Fatigue—Pravastatin—atherosclerosis	0.00138	0.00209	CcSEcCtD
Brinzolamide—Pain—Pravastatin—atherosclerosis	0.00137	0.00207	CcSEcCtD
Brinzolamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00137	0.00207	CcSEcCtD
Brinzolamide—Asthenia—Lovastatin—atherosclerosis	0.00136	0.00206	CcSEcCtD
Brinzolamide—Pruritus—Lovastatin—atherosclerosis	0.00134	0.00203	CcSEcCtD
Brinzolamide—Asthenia—Ezetimibe—atherosclerosis	0.00134	0.00202	CcSEcCtD
Brinzolamide—Nausea—Rosuvastatin—atherosclerosis	0.00133	0.00201	CcSEcCtD
Brinzolamide—Feeling abnormal—Pravastatin—atherosclerosis	0.00132	0.002	CcSEcCtD
Brinzolamide—Pruritus—Ezetimibe—atherosclerosis	0.00132	0.00199	CcSEcCtD
Brinzolamide—Hypersensitivity—Simvastatin—atherosclerosis	0.00131	0.00198	CcSEcCtD
Brinzolamide—Diarrhoea—Lovastatin—atherosclerosis	0.0013	0.00196	CcSEcCtD
Brinzolamide—Urticaria—Niacin—atherosclerosis	0.0013	0.00196	CcSEcCtD
Brinzolamide—Urticaria—Pravastatin—atherosclerosis	0.00128	0.00193	CcSEcCtD
Brinzolamide—Asthenia—Simvastatin—atherosclerosis	0.00127	0.00193	CcSEcCtD
Brinzolamide—Diarrhoea—Ezetimibe—atherosclerosis	0.00127	0.00193	CcSEcCtD
Brinzolamide—Pruritus—Simvastatin—atherosclerosis	0.00126	0.0019	CcSEcCtD
Brinzolamide—Dizziness—Lovastatin—atherosclerosis	0.00126	0.0019	CcSEcCtD
Brinzolamide—Dizziness—Ezetimibe—atherosclerosis	0.00123	0.00186	CcSEcCtD
Brinzolamide—Diarrhoea—Simvastatin—atherosclerosis	0.00122	0.00184	CcSEcCtD
Brinzolamide—Vomiting—Lovastatin—atherosclerosis	0.00121	0.00182	CcSEcCtD
Brinzolamide—Hypersensitivity—Niacin—atherosclerosis	0.0012	0.00182	CcSEcCtD
Brinzolamide—Rash—Lovastatin—atherosclerosis	0.0012	0.00181	CcSEcCtD
Brinzolamide—Dermatitis—Lovastatin—atherosclerosis	0.0012	0.00181	CcSEcCtD
Brinzolamide—Headache—Lovastatin—atherosclerosis	0.00119	0.0018	CcSEcCtD
Brinzolamide—Vomiting—Ezetimibe—atherosclerosis	0.00118	0.00179	CcSEcCtD
Brinzolamide—Hypersensitivity—Pravastatin—atherosclerosis	0.00118	0.00179	CcSEcCtD
Brinzolamide—Dizziness—Simvastatin—atherosclerosis	0.00117	0.00177	CcSEcCtD
Brinzolamide—Rash—Ezetimibe—atherosclerosis	0.00117	0.00177	CcSEcCtD
Brinzolamide—Dermatitis—Ezetimibe—atherosclerosis	0.00117	0.00177	CcSEcCtD
Brinzolamide—Asthenia—Niacin—atherosclerosis	0.00117	0.00177	CcSEcCtD
Brinzolamide—Headache—Ezetimibe—atherosclerosis	0.00117	0.00176	CcSEcCtD
Brinzolamide—Pruritus—Niacin—atherosclerosis	0.00115	0.00174	CcSEcCtD
Brinzolamide—Asthenia—Pravastatin—atherosclerosis	0.00115	0.00174	CcSEcCtD
Brinzolamide—Pruritus—Pravastatin—atherosclerosis	0.00114	0.00172	CcSEcCtD
Brinzolamide—Vomiting—Simvastatin—atherosclerosis	0.00113	0.00171	CcSEcCtD
Brinzolamide—Nausea—Lovastatin—atherosclerosis	0.00113	0.0017	CcSEcCtD
Brinzolamide—Rash—Simvastatin—atherosclerosis	0.00112	0.00169	CcSEcCtD
Brinzolamide—Dermatitis—Simvastatin—atherosclerosis	0.00112	0.00169	CcSEcCtD
Brinzolamide—Diarrhoea—Niacin—atherosclerosis	0.00112	0.00169	CcSEcCtD
Brinzolamide—Headache—Simvastatin—atherosclerosis	0.00111	0.00168	CcSEcCtD
Brinzolamide—Nausea—Ezetimibe—atherosclerosis	0.00111	0.00167	CcSEcCtD
Brinzolamide—Diarrhoea—Pravastatin—atherosclerosis	0.0011	0.00166	CcSEcCtD
Brinzolamide—Dizziness—Niacin—atherosclerosis	0.00108	0.00163	CcSEcCtD
Brinzolamide—Dizziness—Pravastatin—atherosclerosis	0.00106	0.0016	CcSEcCtD
Brinzolamide—Nausea—Simvastatin—atherosclerosis	0.00106	0.00159	CcSEcCtD
Brinzolamide—Vomiting—Niacin—atherosclerosis	0.00104	0.00157	CcSEcCtD
Brinzolamide—Rash—Niacin—atherosclerosis	0.00103	0.00155	CcSEcCtD
Brinzolamide—Dermatitis—Niacin—atherosclerosis	0.00103	0.00155	CcSEcCtD
Brinzolamide—Headache—Niacin—atherosclerosis	0.00102	0.00154	CcSEcCtD
Brinzolamide—Vomiting—Pravastatin—atherosclerosis	0.00102	0.00154	CcSEcCtD
Brinzolamide—Rash—Pravastatin—atherosclerosis	0.00101	0.00153	CcSEcCtD
Brinzolamide—Dermatitis—Pravastatin—atherosclerosis	0.00101	0.00153	CcSEcCtD
Brinzolamide—Headache—Pravastatin—atherosclerosis	0.00101	0.00152	CcSEcCtD
Brinzolamide—Nausea—Niacin—atherosclerosis	0.000969	0.00146	CcSEcCtD
Brinzolamide—Nausea—Pravastatin—atherosclerosis	0.000954	0.00144	CcSEcCtD
Brinzolamide—CA7—Metabolism—HMOX1—atherosclerosis	0.000145	0.00111	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—HMOX1—atherosclerosis	0.000145	0.00111	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GSTM1—atherosclerosis	0.000145	0.00111	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTM1—atherosclerosis	0.000145	0.00111	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CETP—atherosclerosis	0.000143	0.00109	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GPX1—atherosclerosis	0.000142	0.00109	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SCARB1—atherosclerosis	0.000142	0.00109	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—LPL—atherosclerosis	0.000142	0.00109	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—LPL—atherosclerosis	0.000142	0.00109	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK3—atherosclerosis	0.000141	0.00108	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMGCR—atherosclerosis	0.00014	0.00108	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOB—atherosclerosis	0.000139	0.00107	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOB—atherosclerosis	0.000139	0.00107	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GPX1—atherosclerosis	0.000139	0.00106	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GPX1—atherosclerosis	0.000139	0.00106	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CD36—atherosclerosis	0.000139	0.00106	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SCARB1—atherosclerosis	0.000137	0.00105	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTM1—atherosclerosis	0.000135	0.00104	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTM1—atherosclerosis	0.000135	0.00104	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CD36—atherosclerosis	0.000135	0.00104	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CD36—atherosclerosis	0.000135	0.00104	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—HMOX1—atherosclerosis	0.000135	0.00103	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMGCR—atherosclerosis	0.000135	0.00103	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—LPL—atherosclerosis	0.000133	0.00102	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—LPL—atherosclerosis	0.000133	0.00102	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—MTHFR—atherosclerosis	0.000131	0.00101	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NAMPT—atherosclerosis	0.000131	0.001	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LIPC—atherosclerosis	0.00013	0.000996	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GPX1—atherosclerosis	0.00013	0.000993	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GPX1—atherosclerosis	0.00013	0.000993	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOC3—atherosclerosis	0.000129	0.000989	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARA—atherosclerosis	0.000129	0.000988	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMGCR—atherosclerosis	0.000129	0.000988	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOB—atherosclerosis	0.000129	0.000987	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LDLR—atherosclerosis	0.000128	0.000983	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—MTHFR—atherosclerosis	0.000128	0.000982	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—MTHFR—atherosclerosis	0.000128	0.000982	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CD36—atherosclerosis	0.000126	0.000967	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CD36—atherosclerosis	0.000126	0.000967	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARA—atherosclerosis	0.000126	0.000963	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARA—atherosclerosis	0.000126	0.000963	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CETP—atherosclerosis	0.000125	0.000961	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTM1—atherosclerosis	0.000125	0.000961	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCA1—atherosclerosis	0.000125	0.000958	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AGT—atherosclerosis	0.000125	0.000957	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—LPL—atherosclerosis	0.000123	0.000943	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—APOE—atherosclerosis	0.000122	0.000938	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AGT—atherosclerosis	0.000122	0.000933	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AGT—atherosclerosis	0.000122	0.000933	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CAV1—atherosclerosis	0.000121	0.000929	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—APOA1—atherosclerosis	0.000121	0.000927	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SCARB1—atherosclerosis	0.00012	0.00092	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GPX1—atherosclerosis	0.00012	0.00092	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCA1—atherosclerosis	0.00012	0.000919	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—MTHFR—atherosclerosis	0.00012	0.000916	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MTHFR—atherosclerosis	0.00012	0.000916	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—APOE—atherosclerosis	0.000119	0.000914	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—APOE—atherosclerosis	0.000119	0.000914	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CAV1—atherosclerosis	0.000118	0.000905	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CAV1—atherosclerosis	0.000118	0.000905	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—APOA1—atherosclerosis	0.000118	0.000903	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—APOA1—atherosclerosis	0.000118	0.000903	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARA—atherosclerosis	0.000117	0.000899	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARA—atherosclerosis	0.000117	0.000899	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CD36—atherosclerosis	0.000117	0.000896	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCA1—atherosclerosis	0.000115	0.000881	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AGT—atherosclerosis	0.000114	0.000871	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AGT—atherosclerosis	0.000114	0.000871	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMGCR—atherosclerosis	0.000113	0.000869	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOE—atherosclerosis	0.000111	0.000853	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOE—atherosclerosis	0.000111	0.000853	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—MTHFR—atherosclerosis	0.000111	0.000849	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CG—atherosclerosis	0.00011	0.000846	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CAV1—atherosclerosis	0.00011	0.000845	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CAV1—atherosclerosis	0.00011	0.000845	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOA1—atherosclerosis	0.00011	0.000843	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOA1—atherosclerosis	0.00011	0.000843	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARA—atherosclerosis	0.000109	0.000833	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CG—atherosclerosis	0.000108	0.000825	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CG—atherosclerosis	0.000108	0.000825	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMOX1—atherosclerosis	0.000107	0.000822	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—atherosclerosis	0.000107	0.000817	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AGT—atherosclerosis	0.000105	0.000807	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—INS—atherosclerosis	0.000105	0.000801	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—atherosclerosis	0.000104	0.000796	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—atherosclerosis	0.000104	0.000796	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOE—atherosclerosis	0.000103	0.00079	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—atherosclerosis	0.000103	0.000789	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—atherosclerosis	0.000103	0.000788	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOB—atherosclerosis	0.000103	0.000787	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CAV1—atherosclerosis	0.000102	0.000783	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOA1—atherosclerosis	0.000102	0.000781	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—INS—atherosclerosis	0.000102	0.000781	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—INS—atherosclerosis	0.000102	0.000781	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCA1—atherosclerosis	0.000101	0.000774	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CG—atherosclerosis	0.0001	0.00077	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—atherosclerosis	0.0001	0.00077	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—atherosclerosis	0.0001	0.000766	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—atherosclerosis	9.86e-05	0.000756	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOB—atherosclerosis	9.85e-05	0.000755	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—LPL—atherosclerosis	9.81e-05	0.000752	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—atherosclerosis	9.7e-05	0.000743	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—atherosclerosis	9.7e-05	0.000743	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—atherosclerosis	9.59e-05	0.000734	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—atherosclerosis	9.59e-05	0.000734	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GPX1—atherosclerosis	9.58e-05	0.000734	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—INS—atherosclerosis	9.51e-05	0.000729	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—INS—atherosclerosis	9.51e-05	0.000729	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOB—atherosclerosis	9.45e-05	0.000724	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—LPL—atherosclerosis	9.41e-05	0.000721	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—atherosclerosis	9.34e-05	0.000716	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—atherosclerosis	9.34e-05	0.000716	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CD36—atherosclerosis	9.33e-05	0.000714	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—atherosclerosis	9.31e-05	0.000713	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—atherosclerosis	9.19e-05	0.000704	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPX1—atherosclerosis	9.18e-05	0.000703	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NOS3—atherosclerosis	9.17e-05	0.000702	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—LPL—atherosclerosis	9.02e-05	0.000691	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—atherosclerosis	8.99e-05	0.000688	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CD36—atherosclerosis	8.94e-05	0.000685	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NOS3—atherosclerosis	8.94e-05	0.000685	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NOS3—atherosclerosis	8.94e-05	0.000685	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—atherosclerosis	8.84e-05	0.000677	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—INS—atherosclerosis	8.81e-05	0.000675	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GPX1—atherosclerosis	8.8e-05	0.000674	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—atherosclerosis	8.72e-05	0.000668	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—atherosclerosis	8.72e-05	0.000668	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—atherosclerosis	8.67e-05	0.000664	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARA—atherosclerosis	8.67e-05	0.000664	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CD36—atherosclerosis	8.57e-05	0.000657	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—atherosclerosis	8.47e-05	0.000649	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AGT—atherosclerosis	8.4e-05	0.000643	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—atherosclerosis	8.39e-05	0.000642	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NOS3—atherosclerosis	8.34e-05	0.000639	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NOS3—atherosclerosis	8.34e-05	0.000639	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARA—atherosclerosis	8.31e-05	0.000637	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOB—atherosclerosis	8.31e-05	0.000636	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOE—atherosclerosis	8.23e-05	0.00063	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—atherosclerosis	8.17e-05	0.000626	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—atherosclerosis	8.17e-05	0.000626	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAV1—atherosclerosis	8.15e-05	0.000624	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOA1—atherosclerosis	8.13e-05	0.000623	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—atherosclerosis	8.12e-05	0.000622	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—atherosclerosis	8.08e-05	0.000619	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—atherosclerosis	8.08e-05	0.000619	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AGT—atherosclerosis	8.05e-05	0.000617	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARA—atherosclerosis	7.97e-05	0.00061	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	7.95e-05	0.000609	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LPL—atherosclerosis	7.93e-05	0.000608	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOE—atherosclerosis	7.89e-05	0.000604	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	7.84e-05	0.000601	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAV1—atherosclerosis	7.81e-05	0.000599	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOA1—atherosclerosis	7.8e-05	0.000597	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPX1—atherosclerosis	7.74e-05	0.000593	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NOS3—atherosclerosis	7.73e-05	0.000592	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AGT—atherosclerosis	7.72e-05	0.000591	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—atherosclerosis	7.63e-05	0.000585	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—atherosclerosis	7.63e-05	0.000585	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOE—atherosclerosis	7.56e-05	0.000579	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CD36—atherosclerosis	7.54e-05	0.000577	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAV1—atherosclerosis	7.49e-05	0.000574	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOA1—atherosclerosis	7.48e-05	0.000573	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—atherosclerosis	7.42e-05	0.000569	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—atherosclerosis	7.17e-05	0.000549	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—atherosclerosis	7.14e-05	0.000547	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—atherosclerosis	7.12e-05	0.000545	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—atherosclerosis	7.07e-05	0.000542	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—INS—atherosclerosis	7.03e-05	0.000538	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARA—atherosclerosis	7.01e-05	0.000537	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—atherosclerosis	6.87e-05	0.000526	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—atherosclerosis	6.82e-05	0.000523	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AGT—atherosclerosis	6.78e-05	0.00052	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—INS—atherosclerosis	6.74e-05	0.000516	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOE—atherosclerosis	6.65e-05	0.000509	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—atherosclerosis	6.59e-05	0.000505	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAV1—atherosclerosis	6.59e-05	0.000505	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOA1—atherosclerosis	6.57e-05	0.000503	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—INS—atherosclerosis	6.46e-05	0.000495	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—atherosclerosis	6.44e-05	0.000494	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—atherosclerosis	6.18e-05	0.000473	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NOS3—atherosclerosis	6.16e-05	0.000472	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—atherosclerosis	6e-05	0.00046	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—atherosclerosis	5.92e-05	0.000454	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NOS3—atherosclerosis	5.91e-05	0.000453	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—atherosclerosis	5.79e-05	0.000444	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—INS—atherosclerosis	5.68e-05	0.000435	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NOS3—atherosclerosis	5.67e-05	0.000434	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	5.64e-05	0.000432	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—atherosclerosis	5.64e-05	0.000432	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—atherosclerosis	5.4e-05	0.000414	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLTP—atherosclerosis	5.3e-05	0.000406	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—atherosclerosis	5.21e-05	0.000399	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—atherosclerosis	5.18e-05	0.000397	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NOS3—atherosclerosis	4.98e-05	0.000382	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.6e-05	0.000352	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.6e-05	0.000352	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—atherosclerosis	4.56e-05	0.000349	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—atherosclerosis	4.22e-05	0.000323	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—atherosclerosis	4.11e-05	0.000315	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—atherosclerosis	4.11e-05	0.000315	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—atherosclerosis	3.83e-05	0.000294	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—atherosclerosis	3.83e-05	0.000294	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.63e-05	0.000278	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—atherosclerosis	3.55e-05	0.000272	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FABP4—atherosclerosis	3.42e-05	0.000262	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LCAT—atherosclerosis	3.42e-05	0.000262	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOA4—atherosclerosis	3.35e-05	0.000257	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.29e-05	0.000252	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.05e-05	0.000233	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.89e-05	0.000221	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOA2—atherosclerosis	2.89e-05	0.000221	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.89e-05	0.000221	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.89e-05	0.000221	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.85e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—atherosclerosis	2.83e-05	0.000217	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LPA—atherosclerosis	2.75e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—atherosclerosis	2.72e-05	0.000208	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BGN—atherosclerosis	2.67e-05	0.000204	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOA5—atherosclerosis	2.64e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—atherosclerosis	2.6e-05	0.000199	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.45e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—atherosclerosis	2.29e-05	0.000175	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.2e-05	0.000169	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LIPC—atherosclerosis	2.19e-05	0.000168	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOC3—atherosclerosis	2.17e-05	0.000167	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LDLR—atherosclerosis	2.16e-05	0.000166	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CETP—atherosclerosis	2.11e-05	0.000162	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.02e-05	0.000155	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.91e-05	0.000146	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.7e-05	0.00013	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.46e-05	0.000112	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOB—atherosclerosis	1.4e-05	0.000107	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.36e-05	0.000104	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LPL—atherosclerosis	1.34e-05	0.000102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX1—atherosclerosis	1.3e-05	9.98e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CD36—atherosclerosis	1.27e-05	9.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.2e-05	9.21e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARA—atherosclerosis	1.18e-05	9.03e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AGT—atherosclerosis	1.14e-05	8.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOE—atherosclerosis	1.12e-05	8.57e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAV1—atherosclerosis	1.11e-05	8.49e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOA1—atherosclerosis	1.11e-05	8.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.01e-05	7.74e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—atherosclerosis	9.75e-06	7.47e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—INS—atherosclerosis	9.56e-06	7.32e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—atherosclerosis	8.76e-06	6.71e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NOS3—atherosclerosis	8.38e-06	6.42e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	7.67e-06	5.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—atherosclerosis	3.85e-06	2.95e-05	CbGpPWpGaD
